Creatine and the Liver: Metabolism and Possible Interactions.
Barcelos RP, Stefanello ST, Mauriz JL, Gonzalez-Gallego J, Soares FA.
Mini Rev Med Chem. 2016;16(1):12-8. doi: 10.2174/1389557515666150722102613.
Inhibition of METTL3TAB3 m6A modifications via IGF2BP2-dependent mechanisms.
Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM.
Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709. Epub 2022 Apr 13.
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al.
Nat Genet. 1995 May;10(1):111-3. doi: 10.1038/ng0595-111.
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.
Borowczyk K, Piechocka J, Głowacki R, Dhar I, Midtun Ø, Tell GS, Ueland PM, Nygård O, Jakubowski H.
J Intern Med. 2019 Feb;285(2):232-244. doi: 10.1111/joim.12834. Epub 2018 Sep 23.
Homocysteine in Renal Injury.
Long Y, Nie J.
Kidney Dis (Basel). 2016 Jun;2(2):80-7. doi: 10.1159/000444900. Epub 2016 Apr 27.
Homocysteine and cardiovascular disease: cause or effect?
Brattström L, Wilcken DE.
Am J Clin Nutr. 2000 Aug;72(2):315-23. doi: 10.1093/ajcn/72.2.315.
Is renal function the key to disease risk management in elevated homocysteine levels?
Hirata A.
Hypertens Res. 2024 Jul;47(7):1976-1977. doi: 10.1038/s41440-024-01690-y. Epub 2024 May 15.
Isolated Sulfite Oxidase Deficiency.
Bindu PS, Nagappa M, Bharath RD, Taly AB.
2017 Sep 21. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Role of homocysteine in end-stage renal disease.
Wu CC, Zheng CM, Lin YF, Lo L, Liao MT, Lu KC.
Clin Biochem. 2012 Nov;45(16-17):1286-94. doi: 10.1016/j.clinbiochem.2012.05.031. Epub 2012 Jun 6.
Urinary kynurenine as a biomarker for Parkinson's disease.
Bai JH, Zheng YL, Yu YP.
Neurol Sci. 2021 Feb;42(2):697-703. doi: 10.1007/s10072-020-04589-x. Epub 2020 Jul 13.
